The PFAS Wastewater Survey has become a regulatory timing problem, not only a data-collection matter. EPA designed the POTW influent study and the National Sewage Sludge Survey to gather national information on PFAS entering wastewater treatment plants and appearing in sewage sludge. As of September 22, 2026, public reporting indicates that the survey still has not cleared White House review, leaving regulators, utilities, and industrial facilities with incomplete evidence for discharge controls and biosolids risk decisions.

The delay matters because PFAS regulation depends heavily on source identification. Drinking water limits, wastewater discharge controls, and biosolids management all require defensible information about where PFAS enters treatment systems, which industries contribute measurable loads, and how treated sludge may carry PFAS into land application pathways. Without that information, agencies may still act, but their decisions are more likely to rely on narrower datasets, site-specific findings, or conservative assumptions.

Why The PFAS Wastewater Survey Is Delayed

What The PFAS Wastewater Survey Was Meant To Collect

EPA’s study page describes the POTW influent PFAS work and the National Sewage Sludge Survey as efforts to collect data from roughly 400 publicly owned treatment works. EPA submitted the Information Collection Request to the Office of Management and Budget in October 2024, and the public comment period for the draft questionnaire ended on November 12, 2024, according to the EPA study page. Those details place the project in a formal federal information-collection process rather than a voluntary research exercise.

On September 3, 2026, the Washington Post reported that the survey had not yet been approved by OMB and had been delayed nearly two years after its October 2024 submission, compared with a typical review period of about 60 days. The same reporting said the survey was intended to help identify major industrial PFAS dischargers, inform industrial discharge limits, and determine PFAS occurrence in biosolids, according to Washington Post reporting.

Why Review Timing Affects Evidence Quality

A delayed questionnaire does not mean EPA has no PFAS data. EPA, states, utilities, researchers, and industrial facilities have generated PFAS information through other programs. The problem is different: a national survey can create a more consistent evidence base across treatment plants, influent sources, and sewage sludge. If that evidence arrives late, regulatory work may proceed with uneven information about sectors, facilities, and treatment-system pathways.

The PFAS Wastewater Survey also sits between environmental compartments. Influent sampling concerns what reaches treatment plants. Sewage sludge data concerns what remains after treatment and may become biosolids. Industrial source identification concerns upstream facilities that may discharge to publicly owned treatment works. A delay therefore affects more than one rulemaking lane.

Regulatory Uses For Wastewater And Biosolids Data

Discharge Limits Need Source Identification

Industrial discharge regulation under the Clean Water Act depends on knowing which categories contribute pollutants and at what levels. For PFAS, that source picture is still developing. If national data are unavailable, regulators may have more difficulty deciding which industrial categories warrant new or revised limits, which facilities require closer permitting attention, and where pretreatment controls would have the greatest effect.

That does not prove that any single industrial category is responsible for a specific PFAS burden. The available research notes support a narrower statement: the delayed survey was designed to help identify top industrial PFAS dischargers and support limits on industrial discharges. Until those data are collected and assessed, facilities should expect uncertainty rather than assume that the absence of a national result means low regulatory risk.

Biosolids Decisions Have A Data Gap

The biosolids issue is particularly difficult because sewage sludge can reflect a mixture of household, commercial, industrial, and background inputs. EPA’s July 1, 2026 draft guidance for reducing risk from PFOA and PFOS in biosolids is voluntary, and its comment period was extended to October 5, 2026. That schedule means guidance activity has moved forward while the national occurrence data expected from the survey remains unresolved.

This sequencing creates a practical tension. Risk managers need occurrence data to understand where PFAS appears in sewage sludge and at what concentrations. Landowners, utilities, and state agencies need clear criteria to decide when biosolids use may require additional controls. Yet the national study intended to supply concentration data has not produced those results. The evidence gap does not eliminate risk; it limits the precision of risk management.

EPA’s April 2024 drinking water rule for six PFAS and its October 2024 ambient water quality criteria for aquatic life also show why upstream wastewater information matters. Drinking water and surface water programs can set endpoints, but wastewater and biosolids data help identify how PFAS reaches those endpoints. For more in-depth discussions on similar science-policy issues, you can visit the Harvard Science Review.

Compliance Documentation While National Data Is Pending

Facilities Should Avoid Unsupported Assumptions

For regulated companies, the absence of the PFAS Wastewater Survey results should not be treated as evidence that PFAS is absent from operations. A more defensible position is to document what is known, what is unknown, and what assumptions have been made. That includes whether PFAS may enter a site through processing aids, coatings, surfactants, raw materials, maintenance chemicals, water-resistant articles, or supplied mixtures.

Documentation should distinguish verified analytical data from supplier statements, process knowledge, and purchase-record inference. Those categories do not carry the same evidentiary weight. A supplier declaration may help screen materials, but it may not address impurities, historical formulations, or changes in upstream production. Analytical results may be stronger evidence for a sampled stream, but they may not represent every discharge condition or production campaign.

For facility-level planning, Kilburn Chemicals has separately addressed PFAS wastewater surveys and compliance planning, a related issue for sites that need to preserve assumptions before federal survey results are available.

Records Need To Connect Materials, Wastewater, And Sludge

A practical compliance file should connect purchasing, production, wastewater, and waste-management records. The point is not to claim certainty before national data exist. The point is to make future reviews traceable. If EPA or a state agency later identifies a sector or discharge pathway as significant, a facility with organized records can test that finding against its own operations more quickly.

• Maintain a current inventory of materials with known or suspected PFAS relevance, including supplier data and revision dates.
• Identify wastewater discharge points, pretreatment steps, and any sampling results already available.
• Record assumptions used to classify materials, processes, and waste streams when direct PFAS data are unavailable.
• Track biosolids, sludge, or wastewater-related vendor responsibilities where applicable.
• Assign change-review triggers for new suppliers, reformulated products, process changes, or new regulatory notices.

These steps do not substitute for federal survey results. They reduce the risk that a facility will be unable to explain its own PFAS position once regulators ask more specific questions.

PFAS Wastewater Survey Delay Requires Documented Assumptions

Regulatory Risk Is Likely To Remain Uneven

The PFAS Wastewater Survey delay leaves agencies with a difficult choice: wait for national data or move ahead using narrower evidence. Both paths carry limits. Waiting can slow controls on discharges or biosolids pathways that may warrant attention. Acting without the national dataset can produce rules or guidance that affected parties view as incomplete or unevenly supported.

For industrial facilities, the PFAS Wastewater Survey delay should be treated as a documentation warning. The strongest near-term posture is not to predict the final survey results. It is to preserve a clear record of material inputs, wastewater pathways, sludge or waste handling, supplier communications, and uncertainty. That record will not answer every PFAS question, but it can show that compliance decisions were based on available evidence rather than silence in the federal data pipeline.

The regulatory challenge is therefore not only scientific. It is administrative and evidentiary. EPA’s delayed national data collection has left a gap between policy goals and field-level information. Until that gap narrows, companies and regulators will need to be explicit about what their decisions can support, what remains uncertain, and which assumptions should be revisited when national wastewater and biosolids data become available.